455 related articles for article (PubMed ID: 16003112)
1. Stem cell treatment for Parkinson's disease: an update for 2005.
Snyder BJ; Olanow CW
Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
[TBL] [Abstract][Full Text] [Related]
2. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
Levy YS; Stroomza M; Melamed E; Offen D
J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
[TBL] [Abstract][Full Text] [Related]
3. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
Bartlett LE; Mendez I
Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
[TBL] [Abstract][Full Text] [Related]
5. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
Fan Y; Winanto ; Ng SY
Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
7. Cell transplantation for Parkinson's disease: present status.
Drucker-Colín R; Verdugo-Díaz L
Cell Mol Neurobiol; 2004 Jun; 24(3):301-16. PubMed ID: 15206816
[TBL] [Abstract][Full Text] [Related]
8. Clinical translation of stem cell transplantation in Parkinson's disease.
Lindvall O
J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
Hauser RA; Freeman TB; Snow BJ; Nauert M; Gauger L; Kordower JH; Olanow CW
Arch Neurol; 1999 Feb; 56(2):179-87. PubMed ID: 10025423
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
11. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
Linazasoro G
Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
[TBL] [Abstract][Full Text] [Related]
13. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
Anisimov SV
Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
[TBL] [Abstract][Full Text] [Related]
14. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
15. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
Zhang L; Yang H
Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
[TBL] [Abstract][Full Text] [Related]
16. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
Pan-Montojo F; Funk RH
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
[TBL] [Abstract][Full Text] [Related]
17. Cell replacement therapy for Parkinson's disease.
Wijeyekoon R; Barker RA
Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
[TBL] [Abstract][Full Text] [Related]
18. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
[TBL] [Abstract][Full Text] [Related]
19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
20. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
